Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Advanced Solid Tumors”

3,969 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,969 results

Not applicableStudy completedNCT02111889
What this trial is testing

Tumor Kinase Inhibitor Concentrations Measured by PET

Who this might be right for
Disseminated Malignant Neoplasm
Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Active Not RecruitingNCT05339685
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Who this might be right for
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 82
Early research (Phase 1)Study completedNCT00750425
What this trial is testing

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Who this might be right for
Advanced Solid Tumors
AstraZeneca 46
Early research (Phase 1)Not Yet RecruitingNCT07567859
What this trial is testing

HS-10587 in Patients With Advanced Solid Tumors

Who this might be right for
MTAP Deletion
Jiangsu Hansoh Pharmaceutical Co., Ltd. 362
Early research (Phase 1)Study completedNCT02070549
What this trial is testing

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT01755390
What this trial is testing

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sanofi 42
Early research (Phase 1)Study completedNCT00400296
What this trial is testing

R547 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 58
Early research (Phase 1)Looking for participantsNCT06332170
What this trial is testing

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hansoh BioMedical R&D Company 610
Early research (Phase 1)Looking for participantsNCT07260591
What this trial is testing

VSV-02 Compassionate Use in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaBreast Cancer+3 more
The First Affiliated Hospital of Xinxiang Medical College 6
Early research (Phase 1)UnknownNCT06019013
What this trial is testing

QLF3108 in Participants With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT00004059
What this trial is testing

Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Early research (Phase 1)Active Not RecruitingNCT05311397
What this trial is testing

A166 in Patients With Advanced Solid Malignant Tumors

Who this might be right for
Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07605962
What this trial is testing

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

Who this might be right for
Advanced Cancer
United Immunity, co., Ltd. 140
Testing effectiveness (Phase 2)Ended earlyNCT04488003
What this trial is testing

Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations

Who this might be right for
Advanced Solid TumorBRAF Gene MutationBRAF Gene Alteration+6 more
BioMed Valley Discoveries, Inc 104
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Looking for participantsNCT07260305
What this trial is testing

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

Who this might be right for
Advanced or Metastatic Solid Tumors
Kangabio AUSTRALIA LTD PTY 57
Testing effectiveness (Phase 2)Ended earlyNCT04260256
What this trial is testing

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Who this might be right for
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
CellSight Technologies, Inc. 9
Load More Results